Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Clinical trial NCT05465174 · RECRUITING

Trial details

NCT number: NCT05465174
Sponsor: Sabine Mueller, MD, PhD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Craniopharyngioma, Child Craniopharyngioma Recurrent Craniopharyngioma

Start date: 2022-09-12
Primary completion: 2027-03-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.